These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 24792457

  • 21. Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death.
    Zhu DWX, Chu MM, House CM.
    Europace; 2017 Dec 01; 19(12):2007-2014. PubMed ID: 27940933
    [Abstract] [Full Text] [Related]

  • 22. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ.
    Cardiol J; 2013 Dec 01; 20(3):217-9. PubMed ID: 23788293
    [No Abstract] [Full Text] [Related]

  • 23. New approach to implantable cardioverter-defibrillators in small pediatric patients: dorsal positioning of superior vena cava shock lead in a 3-year-old.
    Pedersen SB, Smerup MH, Nielsen JC.
    J Thorac Cardiovasc Surg; 2014 Jul 01; 148(1):358-60. PubMed ID: 24685380
    [No Abstract] [Full Text] [Related]

  • 24. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY, Yam N, Lun KS, Chen RH, Au TW, Yung TC.
    Europace; 2018 Sep 01; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract] [Full Text] [Related]

  • 25. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators.
    Karnik AA, Helm RH, Monahan KM.
    J Cardiovasc Electrophysiol; 2019 Mar 01; 30(3):402-409. PubMed ID: 30576031
    [Abstract] [Full Text] [Related]

  • 26. Ventricular fibrillation storm in a child.
    Einbinder T, Lowenthal A, Fogelman R.
    Europace; 2014 Nov 01; 16(11):1654. PubMed ID: 25344961
    [No Abstract] [Full Text] [Related]

  • 27. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ, Rosengarten JA, Gnanapragasam JP, Haw MP, Morgan JM.
    Europace; 2013 Apr 01; 15(4):523-30. PubMed ID: 23333943
    [Abstract] [Full Text] [Related]

  • 28. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery.
    Schloss EJ, Krebs ME, Gupta M.
    Heart Rhythm; 2014 Oct 01; 11(10):1733-4. PubMed ID: 24931635
    [No Abstract] [Full Text] [Related]

  • 29. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH.
    Circ Arrhythm Electrophysiol; 2009 Dec 01; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract] [Full Text] [Related]

  • 30. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K, Miyazaki S, Ishikawa E, Mukai M, Aoyama D, Nodera M, Kaseno K, Tada H.
    J Cardiovasc Electrophysiol; 2019 Oct 01; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract] [Full Text] [Related]

  • 31. Multi-modality imaging in an exceptional case of aborted sudden cardiac death.
    Sonck J, Tanaka K, Czapla J, Vanderhasselt T, Kayaert P, Scott B, Sutherland G, Van Camp G.
    Int J Cardiol; 2014 Feb 01; 171(2):e57-8. PubMed ID: 24365616
    [No Abstract] [Full Text] [Related]

  • 32. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 33. Inappropriate implantable cardioverter-defibrillator shock induced by electromagnetic interference while taking a shower.
    Fernengel A, Schwer C, Helber U, Dörnberger V.
    Clin Res Cardiol; 2007 Jun 01; 96(6):393-5. PubMed ID: 17453136
    [No Abstract] [Full Text] [Related]

  • 34. ICD triple counting leading to a lethal inappropriate shock.
    Korantzopoulos P, Manolis G, Manolis AG.
    J Cardiovasc Electrophysiol; 2020 Jan 01; 31(1):231-233. PubMed ID: 31778244
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event? A case report].
    Krzyzanowski K, Michałkiewicz D, Wierzbowski R, Gniłka A, Ryczek R, Orski Z, Kubik L.
    Kardiol Pol; 2009 Aug 01; 67(8):927-9. PubMed ID: 19784895
    [Abstract] [Full Text] [Related]

  • 38. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
    Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR.
    Circ Arrhythm Electrophysiol; 2013 Feb 01; 6(1):91-100. PubMed ID: 23275262
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A, Ghidina M.
    J Cardiovasc Med (Hagerstown); 2007 May 01; 8(5):320-3. PubMed ID: 17443096
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.